» Articles » PMID: 25264167

Congenital Myasthenic Syndrome in Japan: Ethnically Unique Mutations in Muscle Nicotinic Acetylcholine Receptor Subunits

Overview
Specialty Neurology
Date 2014 Sep 30
PMID 25264167
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Congenital myasthenic syndromes (CMS) are caused by mutations in genes expressed at the neuromuscular junction. Most CMS patients have been reported in Western and Middle Eastern countries, and only four patients with COLQ mutations have been reported in Japan. We here report six mutations in acetylcholine receptor (AChR) subunit genes in five Japanese patients. Five mutations are novel, and one mutation is shared with a European American patient but with a different haplotype. Among the observed mutations, p.Thr284Pro (p.Thr264Pro according to the legacy annotation) in the epsilon subunit causes a slow-channel CMS. Five other mutations in the delta and epsilon subunits are splice site, frameshift, null, or missense mutations causing endplate AChR deficiency. We also found a heteroallelic p.Met465Thr in the beta subunit in another patient. p.Met465Thr, however, was likely to be polymorphism, because single channel recordings showed mild shortening of channel openings without affecting cell surface expression of AChR, and the minor allelic frequency of p.Met465Thr was 5.1% in the Japanese population. Lack of shared mutant alleles between the Japanese and the other patients suggests that most mutations described here are ethnically unique or de novo in each family.

Citing Articles

Pathophysiology of Childhood-Onset Myasthenia: Abnormalities of Neuromuscular Junction and Autoimmunity and Its Background.

Hayashi M Pathophysiology. 2023; 30(4):599-617.

PMID: 38133144 PMC: 10747330. DOI: 10.3390/pathophysiology30040043.


Impaired gating of γ- and ε-AChR respectively causes Escobar syndrome and fast-channel myasthenia.

Shen X, Nakata T, Mizuno S, Imoto I, Selcen D, Ohno K Ann Clin Transl Neurol. 2023; 10(5):732-743.

PMID: 36891870 PMC: 10187723. DOI: 10.1002/acn3.51756.


Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review.

Ohno K, Ohkawara B, Shen X, Selcen D, Engel A Int J Mol Sci. 2023; 24(4).

PMID: 36835142 PMC: 9961056. DOI: 10.3390/ijms24043730.


Determinants of the repetitive-CMAP occurrence and therapy efficacy in slow-channel myasthenia.

Di L, Chen H, Lu Y, Selcen D, Engel A, Da Y Neurology. 2020; 95(20):e2781-e2793.

PMID: 32907971 PMC: 7734725. DOI: 10.1212/WNL.0000000000010734.


Pharmacological Strategy for Congenital Myasthenic Syndrome with CHRNE Mutations: A Meta-Analysis of Case Reports.

Huang K, Luo Y, Bi F, Yang H Curr Neuropharmacol. 2020; 19(5):718-729.

PMID: 32727330 PMC: 8573743. DOI: 10.2174/1570159X18666200729092332.